Goldman Sachs CEO David Solomon’s 2025 Pay Soars to $47 Million After Strong Deal-Making Year 
Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Exxon Mobil’s XTO Energy Explores Sale of Eagle Ford Shale Assets in South Texas 
BitGo IPO Prices Above Range, Raises $212.8M in Landmark Crypto Market Debut 
Apple China Holiday Sale Offers Discounts Up to 1,000 Yuan on Popular Devices 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Winter Storm Triggers Widespread Flight Cancellations Across U.S. as Airlines Urge Travelers to Rebook 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors 
SEC Drops Gemini Enforcement Case After Full Repayment to Earn Investors 
FSU Criticizes ANZ Over Suncorp Bank Job Cuts Amid Post-Acquisition Commitments 
NTSB Opens Investigation Into Waymo Robotaxis After School Bus Safety Violations in Texas 
FCC Chairman Raises Competition Concerns Over Netflix–Warner Bros. Discovery Deal 
TEANECK, N.J., May 08, 2017 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 22, 2017, to stockholders of record at the close of business on May 31, 2017.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For further information, please visit www.pahc.com.
Contact: Richard Johnson Chief Financial Officer, Phibro Animal Health Corporation +1 201-329-7300 [email protected]
